High Patient Satisfaction for up to 6 Months With OnabotulinumtoxinA Treatment for Upper Facial Lines.

Background: OnabotulinumtoxinA safety and efficacy are well established for upper facial lines (UFL), including forehead lines (FHL), glabellar lines (GL), and crow's feet lines (CFL).

Objective: To investigate the association of onabotulinumtoxinA efficacy with patient-reported psychological impacts and satisfaction in UFL.

Materials And Methods: A pooled analysis of data from 4 pivotal Phase 3 trials (onabotulinumtoxinA vs placebo in FHL ± GL, FHL + GL ± CFL, CFL, and CFL + GL for ≤180 days) evaluated investigator-assessed ≥1-grade severity improvement on the Allergan Facial Wrinkle Scale at Day 30 (responders).

Fascinating or dull? Female students' attitudes towards STEM subjects and careers.

Internationally, the need to advance science, technology, engineering and mathematics (STEM) education is recognized as being vital for meeting social and economic challenges and developing a scientifically, mathematically, and technologically literate citizenry. In many countries, however, there are gender differences in the participation and achievement of girls and women in STEM education and STEM careers, usually to the disadvantage of females. This paper aims to identify challenges to female students' participation in STEM both at post-primary (secondary school) level and beyond in the Irish context.

Improvement of Radial Cheek Lines With Hyaluronic Acid-Based Dermal Filler VYC-17.5L: Results of the BEAM Study.

Background: Radial cheek lines (RCL) may convey an older, potentially less attractive appearance.

Objective: To evaluate the effectiveness of hyaluronic acid-based dermal filler VYC-17.5L for correcting RCL.

[Chagas cardiomyopathy: prognosis in clinical and hemodynamic profile C].

Background: patients with heart failure (HF) who are admitted showing poor perfusion and congestion (clinical-hemodynamic profile C) are the group that evolves with the worst prognosis in decompensated heart failure. However, there is little information in literature on the etiology of cardiopathy influences the outcome of patients in advanced stage.

Objective: to assess the outcome of patients admitted with clinical and hemodynamic profile C and verify the role of the etiology in this phase.

[Anemia in patients with advanced heart failure].

Background: anemia is linked with worsening of progress in patients with heart failure (HF). However, there are few studies of anemia in patients with advanced HF.

Objective: to evaluate the characteristics of anemia in HF at an advanced stage.